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Purpose of the study
HIV maternal-fetal transmission (MFT-HIV) in Argentina
is around 6%, one of the highest rates in Latin America.
Most cases occur in the outskirts of Buenos Aires, a highly
populated, low resources setting where the hospitals of
this study are located. Our objective was to assess reasons,
risk factors and percentage of MFT-HIV, characteristics of
HIV+ pregnant women (PW), and evaluation of preven-
tive measurements.
Methods
Prospective, descriptive, study of HIV+ PW and their new-
borns (NB) from 1997 to 2006 in two hospitals of Buenos
Aires Province, Argentina.
Summary of results
211 HIV+ mother-child binomium were evaluated, and
171 (81%) NB were studied: nine acquired HIV (5.26%)
(at least one PCR+ or ELISA+ at 18 months). Mean
mother's age 26.8 years (15–40): MFT+: 29 years vs. MFT-
: 27.2 years (p = 0.31). Way of HIV acquisition: sexual
(96.2%), intravenous drug use (2.5%), blood transfusion
(1.3%); all TMF+ sexual (p = 0.59).
Seventy-three (42.7%) women began HIV follow-up pre-
vious to pregnancy: 6 TMF+ vs. 67 TMF- (p = 0.13); 19
(11.1%) before 14 weeks: all NFT-; 36 (21%) between 15–
28 weeks: all NFT-, 32 (18.7%) after 29 weeks: all NFT-;
and 11 (6.4%) post-partum: 2 TMF+ vs. 9 TMF- (p =
0.0047).
During pregnancy, 134 (63.5%) women received ART:
AZT (11.5%), AZT-ddI (0.6%), AZT-3TC (3.6%), AZT-
3TC-IDV/RTV (1.2%), AZT-3TC-LPV/RTV (0.6%), AZT-
3TC-NFV (7.9%), AZT-3TC-NVP (66.6%), AZT-3TC-SQV/
RTV (7.9%); 34 MFT- and 3 MFT+ did not receive (p =
0.38) Viral load (VL) measured previous to labor in 73
(42.7%) women: 43 <1000 (58.9%). VL was not available
in 89 MFT- and 9 MFT+ (p = 0.02). 109 (63.7%) were elec-
tive Caesarean: 56 MFT- vs. 3 MFT+ (p = 0.11) In 145
(84.4%) cases, i.v. AZT was administered intra-labor; 4
MFT+ vs. 22 MFT- did not receive intra-partum AZT (p =
0.042) One NB died perinatally (0.58%). Mean gesta-
tional age: 37.9 weeks. MFT-: 38.0 vs. MFT+: 39.1 (p =
0.0302); eight (4.67%) NB premature, all MFT- (p =
0.49). Mean birth weight 2,895.7 g (1,450–4,500). MFT-:
2,884 g vs. MFT+ 3,093 g (p = 0.0938); 42 NB (24.6%)
presented low birth weight; MFT-: 41 vs. MFT+: 1 (p =
0.33).
163 (95.3%) NB received ART: AZT(93.9%), AZT-3TC-
NVP (5.52%), AZT-NVP (0.6%); 6 MFT- and 2 TMF+ did
not (p = 0.013). Nine (5.26%) NB were breastfed, 7 MFT-
vs. 2 MFT+ (p = 0.019).
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Beginning of HIV follow-up post-partum, availability of
VL result at the moment of delivery, AZT intra-partum,
higher gestational age, lack of administration of ART to
the newborn, and breastfeeding were significant for HIV-
MFT. It is mandatory to re-affirm the importance of the
fulfillment of measures destined to diminish the proba-
bility of HIV-MFT.Page 2 of 2
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